2016 International Congress Archives - Page 41 of 207

12:00pm-1:30pm: Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease

J.R. Zhang, J. Chen, Z.J. Yang, H.J. Zhang, Y.T. Fu, Y. Shen, P.C. He, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)

Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Recruitment of single subthalamic neurons for kinematic control of hand and feet movements employs different strategies

A. Tankus, A. Mirelman, N. Giladi, I. Fried, J.M. Hausdorff (Tel-Aviv, Israel)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Refined basal ganglia model accounting for GPi modulation of thalamic tonic and burst modes

M.S. Baron, D. Kumbhare (Richmond, VA, USA)

Neurophysiology (non-PD) · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Relation between personality trait and depression in Parkinson’s disease

A. Kumon, Y. Kobayashi, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

Parkinson's disease: Psychiatric manifestations · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Relation between the clinical features and the standardized heart to mediastinum ratio in cardiac metaiodobenzylguanidine imaging in patients with Parkinson’s disease: A multicenter cross-sectional study

T. Osada, Y. Morita, K. Ohta, S. Nogawa, K. Takahashi, K. Yamaguchi, D. Yasutomi, M. Seki, Y. Nihei, S. Iwasawa, N. Suzuki (Tokyo, Japan)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Relationship between freezing and pedunculopontine nucleus’ size in Parkinson’s disease: Semi quantitative analysis based on MRI with modified FGATIR sequence

S. Chen, M. Tir, P. Monet, J.M. Constans, O. Godefroy, M. Lefranc, P. Krystkowiak (Amiens, France)

Parkinson's disease: Neuroimaging and neurophysiology · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Relationship between sensory augmentation and exercise routine in the improvement in balance and gait in a patient with lithium-induced ataxia

M.D. Maldonado (Santiago, Chile)

Ataxia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Relationship of MDS-UPDRS non-motor symptoms to cognitive functioning in patients with Parkinson’s disease

B.A. Bernard, D. Carns, G.T. Stebbins, J.G. Goldman, C.G. Goetz (Chicago, IL, USA)

Cognitive disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Reliability of a newly developed protocol for fiberoptic endoscopic evaluation of swallowing in Parkinson’s patients (PARK-FEES)

J.A. Simons, S. von Clarmann, T. Warnecke (Lübeck, Germany)

Rating scales · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?

M.R. Olchik, M. Ghisi, A. Freiry, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)

Parkinson's disease: Cognition · Exhibit Hall located in Hall B, Level 2